Fig. 1From: Impact of renal function-based anti-tuberculosis drug dosage adjustment on efficacy and safety outcomes in pulmonary tuberculosis complicated with chronic kidney diseaseEligibility flow chart for the study subjects. CKD: chronic kidney disease; EMB: ethambutol; INH: isoniazid; PZA: pyrazinamide; RMP: rifampicin; TB: tuberculosisBack to article page